It is known that inhibition of mTOR pathway correlates with decreasing of angiogenesis: in fact, rapamycin is able to reduce tumour vascularisation by promoting endothelial cell death and inducing increased susceptibility of tumour-specific vessels to thrombosis (Guba et al, 2005). This evidence concerns the gene MTOR and neoplasm.